Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Departing FDA Head Gottlieb Advises Successor Sharpless To Heed Center Directors, Defends Budget To Congress

Executive Summary

In addition to sharing parting advice he gave to incoming acting US FDA Commissioner Ned Sharpless on leading the agency, current FDA chief Scott Gottlieb told the House Appropriations Committee’s Agriculture, Rural Development and FDA Subcommittee on April 3 that the proposed fiscal year 2020 budget would support a new “knowledge management system” at the agency to make reviews of device product applications more efficient.

You may also be interested in...

Gottlieb Leaves FDA With Final Thought On What To Do About Cosmetics

Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.

NCI Director And Former Dx Start-Up Founder Sharpless Will Helm FDA

After a week of speculation as to who will succeed US FDA Commissioner Scott Gottlieb when he steps down next month, Health and Human Services Secretary Alex Azar announced during a congressional hearing that National Cancer Institute Director Ned Sharpless will step in as acting commissioner. One note of medtech interest in Sharpless' bio: he was a co-founder of a diagnostics company.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts